Reversing cachexia
- PMID: 20723750
- DOI: 10.1016/j.cell.2010.08.004
Reversing cachexia
Abstract
Muscle atrophy (cachexia) in cancer patients is a life-threatening condition for which therapeutic options are limited. Zhou et al. (2010) now identify a new target for treating cachexia, the activin type-2 receptor (ActRIIB). In several mouse models of cachexia, the authors reversed wasting of skeletal and cardiac muscle and increased life span by blocking ActRIIB with a decoy receptor.
Copyright 2010 Elsevier Inc. All rights reserved.
Comment on
-
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.Cell. 2010 Aug 20;142(4):531-43. doi: 10.1016/j.cell.2010.07.011. Cell. 2010. PMID: 20723755
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources